A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session93adb3ffc0e5ef7ac8e8d740004e82d3c6910bfc): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Biomarker Market Insights, Forecast to 2034

img

Global Biomarker Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Biomarker Market Insights, Forecast to 2034

Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker is "a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention."
Market Analysis and InsightsGlobal Biomarker Market
Global Biomarker market is expected to reach to US$ 33190 million in 2023, with a positive growth of %, compared with US$ 28570 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Biomarker industry is evaluated to reach US$ 68010 million in 2033. The CAGR will be 12.7% during 2023 to 2033.
Globally, Biomarker key companies include F. Hoffmann-La Roche Ltd., Abbott, Epigenomics AG, General Electric, Johnson & Johnson Services, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH and QIAGEN, etc. F. Hoffmann-La Roche Ltd., Abbott, Epigenomics AG are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Biomarker were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Biomarker market and estimated to attract more attentions from industry insiders and investors.
Biomarker can be divided into Consumables and Service, etc. Consumables is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Biomarker is widely used in various fields, such as Diagnostics Development, Drug Discovery and Development, Disease-Risk and Other, etc. Diagnostics Development provides greatest supports to the Biomarker industry development. In 2022, global % revenue of Biomarker went into Diagnostics Development filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Biomarker market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Biomarker market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


F. Hoffmann-La Roche Ltd.
Abbott
Epigenomics AG
General Electric
Johnson & Johnson Services, Inc.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Siemens Healthcare GmbH
QIAGEN
Segment by Type
Consumables
Service

Segment by Application


Diagnostics Development
Drug Discovery and Development
Disease-Risk
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Biomarker introduction, etc. Biomarker Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Biomarker
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomarker Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Consumables
1.2.3 Service
1.3 Market by Application
1.3.1 Global Biomarker Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Diagnostics Development
1.3.3 Drug Discovery and Development
1.3.4 Disease-Risk
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biomarker Market Perspective (2018-2033)
2.2 Global Biomarker Growth Trends by Region
2.2.1 Biomarker Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Biomarker Historic Market Size by Region (2018-2023)
2.2.3 Biomarker Forecasted Market Size by Region (2024-2033)
2.3 Biomarker Market Dynamics
2.3.1 Biomarker Industry Trends
2.3.2 Biomarker Market Drivers
2.3.3 Biomarker Market Challenges
2.3.4 Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Biomarker by Players
3.1.1 Global Biomarker Revenue by Players (2018-2023)
3.1.2 Global Biomarker Revenue Market Share by Players (2018-2023)
3.2 Global Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biomarker, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Biomarker Market Concentration Ratio
3.4.1 Global Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomarker Revenue in 2022
3.5 Global Key Players of Biomarker Head office and Area Served
3.6 Global Key Players of Biomarker, Product and Application
3.7 Global Key Players of Biomarker, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomarker Breakdown Data by Type
4.1 Global Biomarker Historic Market Size by Type (2018-2023)
4.2 Global Biomarker Forecasted Market Size by Type (2024-2033)
5 Biomarker Breakdown Data by Application
5.1 Global Biomarker Historic Market Size by Application (2018-2023)
5.2 Global Biomarker Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Biomarker Market Size (2018-2033)
6.2 North America Biomarker Market Size by Type
6.2.1 North America Biomarker Market Size by Type (2018-2023)
6.2.2 North America Biomarker Market Size by Type (2024-2033)
6.2.3 North America Biomarker Market Share by Type (2018-2033)
6.3 North America Biomarker Market Size by Application
6.3.1 North America Biomarker Market Size by Application (2018-2023)
6.3.2 North America Biomarker Market Size by Application (2024-2033)
6.3.3 North America Biomarker Market Share by Application (2018-2033)
6.4 North America Biomarker Market Size by Country
6.4.1 North America Biomarker Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Biomarker Market Size by Country (2018-2023)
6.4.3 North America Biomarker Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Biomarker Market Size (2018-2033)
7.2 Europe Biomarker Market Size by Type
7.2.1 Europe Biomarker Market Size by Type (2018-2023)
7.2.2 Europe Biomarker Market Size by Type (2024-2033)
7.2.3 Europe Biomarker Market Share by Type (2018-2033)
7.3 Europe Biomarker Market Size by Application
7.3.1 Europe Biomarker Market Size by Application (2018-2023)
7.3.2 Europe Biomarker Market Size by Application (2024-2033)
7.3.3 Europe Biomarker Market Share by Application (2018-2033)
7.4 Europe Biomarker Market Size by Country
7.4.1 Europe Biomarker Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Biomarker Market Size by Country (2018-2023)
7.4.3 Europe Biomarker Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Biomarker Market Size (2018-2033)
8.2 China Biomarker Market Size by Type
8.2.1 China Biomarker Market Size by Type (2018-2023)
8.2.2 China Biomarker Market Size by Type (2024-2033)
8.2.3 China Biomarker Market Share by Type (2018-2033)
8.3 China Biomarker Market Size by Application
8.3.1 China Biomarker Market Size by Application (2018-2023)
8.3.2 China Biomarker Market Size by Application (2024-2033)
8.3.3 China Biomarker Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Biomarker Market Size (2018-2033)
9.2 Asia Biomarker Market Size by Type
9.2.1 Asia Biomarker Market Size by Type (2018-2023)
9.2.2 Asia Biomarker Market Size by Type (2024-2033)
9.2.3 Asia Biomarker Market Share by Type (2018-2033)
9.3 Asia Biomarker Market Size by Application
9.3.1 Asia Biomarker Market Size by Application (2018-2023)
9.3.2 Asia Biomarker Market Size by Application (2024-2033)
9.3.3 Asia Biomarker Market Share by Application (2018-2033)
9.4 Asia Biomarker Market Size by Region
9.4.1 Asia Biomarker Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Biomarker Market Size by Region (2018-2023)
9.4.3 Asia Biomarker Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Biomarker Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Biomarker Market Size by Type
10.2.1 Middle East, Africa, and Latin America Biomarker Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Biomarker Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Biomarker Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Biomarker Market Size by Application
10.3.1 Middle East, Africa, and Latin America Biomarker Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Biomarker Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Biomarker Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Biomarker Market Size by Country
10.4.1 Middle East, Africa, and Latin America Biomarker Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Biomarker Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Biomarker Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 F. Hoffmann-La Roche Ltd. Company Details
11.1.2 F. Hoffmann-La Roche Ltd. Business Overview
11.1.3 F. Hoffmann-La Roche Ltd. Biomarker Introduction
11.1.4 F. Hoffmann-La Roche Ltd. Revenue in Biomarker Business (2018-2023)
11.1.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Biomarker Introduction
11.2.4 Abbott Revenue in Biomarker Business (2018-2023)
11.2.5 Abbott Recent Developments
11.3 Epigenomics AG
11.3.1 Epigenomics AG Company Details
11.3.2 Epigenomics AG Business Overview
11.3.3 Epigenomics AG Biomarker Introduction
11.3.4 Epigenomics AG Revenue in Biomarker Business (2018-2023)
11.3.5 Epigenomics AG Recent Developments
11.4 General Electric
11.4.1 General Electric Company Details
11.4.2 General Electric Business Overview
11.4.3 General Electric Biomarker Introduction
11.4.4 General Electric Revenue in Biomarker Business (2018-2023)
11.4.5 General Electric Recent Developments
11.5 Johnson & Johnson Services, Inc.
11.5.1 Johnson & Johnson Services, Inc. Company Details
11.5.2 Johnson & Johnson Services, Inc. Business Overview
11.5.3 Johnson & Johnson Services, Inc. Biomarker Introduction
11.5.4 Johnson & Johnson Services, Inc. Revenue in Biomarker Business (2018-2023)
11.5.5 Johnson & Johnson Services, Inc. Recent Developments
11.6 Thermo Fisher Scientific Inc.
11.6.1 Thermo Fisher Scientific Inc. Company Details
11.6.2 Thermo Fisher Scientific Inc. Business Overview
11.6.3 Thermo Fisher Scientific Inc. Biomarker Introduction
11.6.4 Thermo Fisher Scientific Inc. Revenue in Biomarker Business (2018-2023)
11.6.5 Thermo Fisher Scientific Inc. Recent Developments
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Details
11.7.2 Bio-Rad Laboratories, Inc. Business Overview
11.7.3 Bio-Rad Laboratories, Inc. Biomarker Introduction
11.7.4 Bio-Rad Laboratories, Inc. Revenue in Biomarker Business (2018-2023)
11.7.5 Bio-Rad Laboratories, Inc. Recent Developments
11.8 Siemens Healthcare GmbH
11.8.1 Siemens Healthcare GmbH Company Details
11.8.2 Siemens Healthcare GmbH Business Overview
11.8.3 Siemens Healthcare GmbH Biomarker Introduction
11.8.4 Siemens Healthcare GmbH Revenue in Biomarker Business (2018-2023)
11.8.5 Siemens Healthcare GmbH Recent Developments
11.9 QIAGEN
11.9.1 QIAGEN Company Details
11.9.2 QIAGEN Business Overview
11.9.3 QIAGEN Biomarker Introduction
11.9.4 QIAGEN Revenue in Biomarker Business (2018-2023)
11.9.5 QIAGEN Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biomarker Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Consumables
Table 3. Key Players of Service
Table 4. Global Biomarker Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Biomarker Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Biomarker Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Biomarker Market Share by Region (2018-2023)
Table 8. Global Biomarker Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Biomarker Market Share by Region (2024-2033)
Table 10. Biomarker Market Trends
Table 11. Biomarker Market Drivers
Table 12. Biomarker Market Challenges
Table 13. Biomarker Market Restraints
Table 14. Global Biomarker Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Biomarker Revenue Share by Players (2018-2023)
Table 16. Global Top Biomarker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker as of 2022)
Table 17. Global Biomarker Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Biomarker Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Biomarker, Headquarters and Area Served
Table 20. Global Key Players of Biomarker, Product and Application
Table 21. Global Key Players of Biomarker, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biomarker Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Biomarker Revenue Market Share by Type (2018-2023)
Table 25. Global Biomarker Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Biomarker Revenue Market Share by Type (2024-2033)
Table 27. Global Biomarker Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Biomarker Revenue Share by Application (2018-2023)
Table 29. Global Biomarker Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Biomarker Revenue Share by Application (2024-2033)
Table 31. North America Biomarker Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Biomarker Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Biomarker Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Biomarker Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Biomarker Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Biomarker Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Biomarker Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Biomarker Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Biomarker Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Biomarker Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Biomarker Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Biomarker Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Biomarker Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Biomarker Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Biomarker Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Biomarker Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Biomarker Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Biomarker Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Biomarker Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Biomarker Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Biomarker Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Biomarker Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Biomarker Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Biomarker Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Biomarker Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Biomarker Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Biomarker Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Biomarker Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Biomarker Market Size by Country (2024-2033) & (US$ Million)
Table 63. F. Hoffmann-La Roche Ltd. Company Details
Table 64. F. Hoffmann-La Roche Ltd. Business Overview
Table 65. F. Hoffmann-La Roche Ltd. Biomarker Product
Table 66. F. Hoffmann-La Roche Ltd. Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 67. F. Hoffmann-La Roche Ltd. Recent Developments
Table 68. Abbott Company Details
Table 69. Abbott Business Overview
Table 70. Abbott Biomarker Product
Table 71. Abbott Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 72. Abbott Recent Developments
Table 73. Epigenomics AG Company Details
Table 74. Epigenomics AG Business Overview
Table 75. Epigenomics AG Biomarker Product
Table 76. Epigenomics AG Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 77. Epigenomics AG Recent Developments
Table 78. General Electric Company Details
Table 79. General Electric Business Overview
Table 80. General Electric Biomarker Product
Table 81. General Electric Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 82. General Electric Recent Developments
Table 83. Johnson & Johnson Services, Inc. Company Details
Table 84. Johnson & Johnson Services, Inc. Business Overview
Table 85. Johnson & Johnson Services, Inc. Biomarker Product
Table 86. Johnson & Johnson Services, Inc. Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 87. Johnson & Johnson Services, Inc. Recent Developments
Table 88. Thermo Fisher Scientific Inc. Company Details
Table 89. Thermo Fisher Scientific Inc. Business Overview
Table 90. Thermo Fisher Scientific Inc. Biomarker Product
Table 91. Thermo Fisher Scientific Inc. Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 92. Thermo Fisher Scientific Inc. Recent Developments
Table 93. Bio-Rad Laboratories, Inc. Company Details
Table 94. Bio-Rad Laboratories, Inc. Business Overview
Table 95. Bio-Rad Laboratories, Inc. Biomarker Product
Table 96. Bio-Rad Laboratories, Inc. Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 97. Bio-Rad Laboratories, Inc. Recent Developments
Table 98. Siemens Healthcare GmbH Company Details
Table 99. Siemens Healthcare GmbH Business Overview
Table 100. Siemens Healthcare GmbH Biomarker Product
Table 101. Siemens Healthcare GmbH Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 102. Siemens Healthcare GmbH Recent Developments
Table 103. QIAGEN Company Details
Table 104. QIAGEN Business Overview
Table 105. QIAGEN Biomarker Product
Table 106. QIAGEN Revenue in Biomarker Business (2018-2023) & (US$ Million)
Table 107. QIAGEN Recent Developments
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biomarker Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Biomarker Market Share by Type: 2022 VS 2033
Figure 3. Consumables Features
Figure 4. Service Features
Figure 5. Global Biomarker Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Biomarker Market Share by Application: 2022 VS 2033
Figure 7. Diagnostics Development Case Studies
Figure 8. Drug Discovery and Development Case Studies
Figure 9. Disease-Risk Case Studies
Figure 10. Other Case Studies
Figure 11. Biomarker Report Years Considered
Figure 12. Global Biomarker Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Biomarker Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Biomarker Market Share by Region: 2022 VS 2033
Figure 15. Global Biomarker Market Share by Players in 2022
Figure 16. Global Top Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Biomarker Revenue in 2022
Figure 18. North America Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Biomarker Market Share by Type (2018-2033)
Figure 20. North America Biomarker Market Share by Application (2018-2033)
Figure 21. North America Biomarker Market Share by Country (2018-2033)
Figure 22. United States Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Biomarker Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Biomarker Market Share by Type (2018-2033)
Figure 26. Europe Biomarker Market Share by Application (2018-2033)
Figure 27. Europe Biomarker Market Share by Country (2018-2033)
Figure 28. Germany Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Biomarker Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Biomarker Market Share by Type (2018-2033)
Figure 36. China Biomarker Market Share by Application (2018-2033)
Figure 37. Asia Biomarker Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Biomarker Market Share by Type (2018-2033)
Figure 39. Asia Biomarker Market Share by Application (2018-2033)
Figure 40. Asia Biomarker Market Share by Region (2018-2033)
Figure 41. Japan Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Biomarker Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Biomarker Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Biomarker Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Biomarker Market Share by Country (2018-2033)
Figure 51. Brazil Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Biomarker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 58. Abbott Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 59. Epigenomics AG Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 60. General Electric Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 61. Johnson & Johnson Services, Inc. Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 62. Thermo Fisher Scientific Inc. Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 63. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 64. Siemens Healthcare GmbH Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 65. QIAGEN Revenue Growth Rate in Biomarker Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries